Thoracic Tumours Register
Observational, multicenter study in patients with lung cancer and other thoracic tumors. The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response
| Condition(s) | Thoracic Tumors |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Observational, multicenter study in patients with lung cancer and other thoracic tumors. The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents and molecular inhibitors of cell proliferation as one of its primary objectives. This could significantly improve the prognosis of patients with lung cancer, and will lead to a radical change in routine clinical practice. The aim of the register is to explore all data available of all patients treated because of thoracic tumours. |
| Who can participate | Inclusion Criteria: * Patients with thoracic disease, treated with an active treatment or not treated (only palliative care) Exclusion Criteria: * Patients with other type of tumours |
| Sex | All |
| Lead sponsor | Spanish Lung Cancer Group |
| Locations | Ferrol, A Coruña, Spain; Albacete, Albacete, Spain; Alcoy, Alicante, Spain; Alicante, Alicante, Spain; Elche, ALICANTE, Spain; Elda, Alicante, Spain (+73 more sites) |
| Start date | 2016-07-21 |
| NCT ID | NCT02941458 |
| Official listing | https://clinicaltrials.gov/study/NCT02941458 |